Paul B Leurs

Summary

Affiliation: Oosterschelde Hospital
Country: The Netherlands

Publications

  1. ncbi Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes
    Paul B Leurs
    Department of Endocrinology, University Hospital, Maastricht, The Netherlands
    Diabetes Care 25:1340-5. 2002
  2. ncbi Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuria
    P B Leurs
    Department of Internal Medicine, University Hospital, Maastricht, The Netherlands
    Diabet Med 20:16-22. 2003

Detail Information

Publications2

  1. ncbi Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes
    Paul B Leurs
    Department of Endocrinology, University Hospital, Maastricht, The Netherlands
    Diabetes Care 25:1340-5. 2002
    ..Endothelial damage precedes atherosclerotic changes of the vascular wall. Therefore, several markers of endothelial dysfunction were examined in elderly subjects with IGT and elderly patients with type 2 diabetes...
  2. ncbi Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuria
    P B Leurs
    Department of Internal Medicine, University Hospital, Maastricht, The Netherlands
    Diabet Med 20:16-22. 2003
    ..To study heparin-stimulated TFPI release in relation to complications in Type 1 diabetic patients...